Anhedonia revisited: Is there a role for dopamine-targeting drugs for depression?

Journal of Psychopharmacology

Volumn 27, Issue 10, 2013, Pages 869-877

  Argyropoulos, Spilios V ^a   Nutt, David J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Anhedonia; appetitive; depression; dopamine; hedonic behaviour; motivational

Indexed keywords

AMFEBUTAMONE; CATECHOLAMINE; DOPAMINE; ESCITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE;

ANHEDONIA; ANTERIOR CINGULATE; BIPOLAR DEPRESSION; BRAIN REGION; DEPRESSION; DISEASE ASSOCIATION; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFICACY; EMOTIONALITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIMBIC SYSTEM; LOW DRUG DOSE; NERVE CELL NETWORK; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; REWARD;

ANHEDONIA; APPETITIVE; DEPRESSION; DOPAMINE; HEDONIC BEHAVIOUR; MOTIVATIONAL;

ANHEDONIA; ANIMALS; DEPRESSION; DOPAMINE AGONISTS; HUMANS;

EID: 84883883042     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113494104     Document Type: Review

References (99)

1. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV). Washington DC: APA ; 1994 :
2. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR). Washington DC: APA ; 2000 :
3. Argyropoulos SV, Nutt DJ. Anhedonia and chronic mild stress model in depression. Psychopharmacol. 1997 ; 134: 333-336
4. Berrios GE The History of Mental Symptoms. Descriptive Psychopathology since the Nineteenth Century. Cambridge: Cambridge University Press ; 1996 :
5. Bjorklund A, Dunnett SB. Dopamine neuron systems in the brain: An update. Trends Neurosci. 2007 ; 30: 194-202
6. Breiter HC, Rosen BR. Functional magnetic resonance imaging of brain reward circuitry in the human. Ann NY Acad Sci. 1999 ; 877: 523-547
7. Bressan RA, Crippa JA. The role of dopamine in reward and pleasure behaviour: Review of data from preclinical research. Acta Psychiatr Scand Suppl. 2005 ; 427: 14-21
8. Buckner JD, Joiner TE Jr, Pettit JW, et al. Implications of the DSM's emphasis on sadness and anhedonia in major depressive disorder. Psychiatry Res. 2008 ; 159: 25-30
9. Bylsma LM, Morris BH, Rottenberg J. A meta-Analysis of emotional reactivity in major depressive disorder. Clin Psychol Rev. 2008 ; 28: 676-691
10. Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol. 1976 ; 85: 374-382
11. Chiaroni P, Azorin JM, Dassa D, et al. Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder. Psychiatr Genet. 2000 ; 10: 43-49
12. Clark DA, Steer RA, Beck AT. Common and specific dimensions of self-reported anxiety and depression: Implications for the cognitive and tripartite models. J Abnorm Psychol. 1994 ; 103: 645-654
13. Colasanti A, Searle GE, Long CJ, et al. Endogenous opioid release in the human brain reward system induced by acute amphetamine administration. Biol Psychiatry. 2012 ; 72: 371-377
14. Cowen MS, Krstew E, Lawrence AJ. Assessing appetitive and consummatory phases of ethanol self-Administration in C57BL/6J mice under operant conditions: Regulation by mGlu5 receptor antagonism. Psychopharmacol. 2007 ; 190: 21-29
15. Cumming P, Caprioli D, Dalley JW. What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?. Br J Pharmacol. 2011 ; 163: 1586-1604
16. Cummings JL, Masterman DL. Depression in patients with Parkinson's disease. Int J Geriatr Psychiatry. 1999 ; 14: 711-718
17. Czernecki V, Pillon B, Houeto JL, et al. Motivation, reward, and Parkinson's disease: Influence of dopatherapy. Neuropsychologia. 2002 ; 40: 2257-2267
18. D'Haenen H. Measurement of anhedonia. Eur Psychiatry. 1996 ; 7: 335-343
19. Dikeos DG, Papadimitriou GN, Avramopoulos D, et al. Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder. Psychiatr Genet. 1999 ; 9: 189-195
20. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007 ; 64: 327-337
21. Epstein J, Pan H, Kocsis JH, et al. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry. 2006 ; 163: 1784-1790
22. Etain B, Roy I, Henry C, et al. No evidence for physical anhedonia as a candidate symptom or an endophenotype in bipolar affective disorder. Bipolar Disord. 2007 ; 9: 706-712
23. Farde L, Gustavsson JP, Jonsson E. D2 dopamine receptors and personality traits. Nature. 1997 ; 385: 590
24. Fawcett J, Clark DC, Scheftner WA, et al. Assessing anhedonia in psychiatric patients. Arch Gen Psychiatry. 1983 ; 40: 79-84
25. Fountoulakis KN, Vieta E, Schmidt F. Aripiprazole monotherapy in the treatment of bipolar disorder: A meta-Analysis. J Affect Disord. 2011 ; 133: 361-370
26. Franken IH, Rassin E, Muris P. The assessment of anhedonia in clinical and non-clinical populations: Further validation of the Snaith-Hamilton Pleasure Scale (SHAPS). J Affect Disord. 2007 ; 99: 83-89
27. Gard DE, Gard MG, Kring AM, et al. Anticipatory and consummatory components of the experience of pleasure: A scale development study. J Res Pers. 2006 ; 40: 1086-1102
28. Gard DE, Kring AM, Gard MG, et al. Anhedonia in schizophrenia: Distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007 ; 93: 253-260
29. Germans MK, Kring AM. Hedonic deficit in anhedonia: Support for the role of approach motivation. Personal Indiv Diff. 2000 ; 28: 659-672
30. Giles DE, Roffwarg HP, Schlesser MA, et al. Which endogenous depressive symptoms relate to REM latency reduction?. Biol Psychiatry. 1986 ; 21: 473-482
31. Gold JM, Waltz JA, Prentice KJ, et al. Reward processing in schizophrenia: A deficit in the representation of value. Schizophr Bull. 2008 ; 34: 835-847
32. Gorwood P. Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci. 2008 ; 10: 291-299
33. Harmer CJ, Mackay CE, Reid CB, et al. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry. 2006 ; 59: 816-820
34. Hasler G, Fromm S, Carlson PJ, et al. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry. 2008 ; 65: 531-531
35. Insel TR. Translating scientific opportunity into public health impact: A strategic plan for research on mental illness. Arch Gen Psychiatry. 2009 ; 66: 128-133
36. Kapur S, Mann JJ. Role of the dopaminergic system in depression. Biol Psychiatry. 1992 ; 32: 1-17
37. Keedwell PA, Andrew C, Williams SC, et al. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry. 2005 ; 58: 843-853
38. Kennedy SH, Evans KR, Kruger S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry. 2001 ; 158: 899-905
39. Klein DF. Endogenomorphic depression. A conceptual and terminological revision. Arch Gen Psychiatry. 1974 ; 31: 447-454
40. Knutson B, Cooper JC. Functional magnetic resonance imaging of reward prediction. Curr Opin Neurol. 2005 ; 18: 411-417
41. Komossa K, Depping AM, Gaudchau A, et al. Second-generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database Syst Rev. 2010 ; 12: CD008121
42. Koob GF. Hedonic valence, dopamine and motivation. Mol Psychiatry. 1996 ; 1: 186-189
43. Korf J, Van Praag HM. Psychopharmacol. 1971 ; 19: 199-203
44. Lemke MR, Puhl P, Koethe N, et al. Psychomotor retardation and anhedonia in depression. Acta Psychiatr Scand. 1999 ; 99: 252-256
45. Leventhal AM, Chasson GS, Tapia E, et al. Measuring hedonic capacity in depression: A psychometric analysis of three anhedonia scales. J Clin Psychol. 2006 ; 62: 1545-1558
46. Light SN, Heller AS, Johnstone T, et al. Reduced right ventrolateral prefrontal cortex activity while inhibiting positive affect is associated with improvement in hedonic capacity after 8 weeks of antidepressant treatment in major depressive disorder. Biol Psychiatry. 2011 ; 70: 962-968
47. Liu WH, Chan R, Wang LZ, et al. Deficits in sustaining reward responses in subsyndromal and syndromal major depression. Prog Neuropharmacol Biol Psychiatry. 2011 ; 35: 1045-1052
48. Loas G. Anhedonia and suicide: A 6.5-yr. follow-up study of patients hospitalised for a suicide attempt. Psychol Rep. 2007 ; 100: 183-190
49. Lopez-Leon S, Croes EA, Sayed-Tabatabaei FA. The dopamine D4 receptor gene 48- base-pair-repeat polymorphism and mood disorders: A meta-Analysis. Biol Psychiatry. 2005 ; 57: 999-1003
50. McCabe C, Cowen PJ, Harmer CJ. Neural representation of reward in recovered depressed patients. Psychopharmacol. 2009 ; 205: 667-677
51. McCabe C, Huber A, Harmer CJ, et al. The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers. Psychopharmacol. 2011 ; 217: 271-278
52. McCabe C, Woffindale C, Harmer CJ, et al. Neural processing of reward in young people at increased familial risk of depression. Biol Psychiatry. 2012 ; 72: 588-594
53. McFarland BR, Klein DN. Emotional reactivity in depression: Diminished responsiveness to anticipated reward but not to anticipated punishment or to nonreward or avoidance. Depress Anxiety. 2009 ; 26: 117-122
54. McGlinchey JB, Zimmerman M, Young D, et al. Diagnosing major depressive disorder VIII: Are some symptoms better than others?. J Nerv Ment Dis. 2006 ; 194: 785-790
55. McIntyre RS. Aripiprazole: Striving towards euthymia with a novel mechanism of action. J Affect Disord. 2011 ; 128: S1-2
56. McMakin DL, Olino TM, Porta G, et al. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. J Am Acad Child Adolesc Psychiatry. 2012 ; 51: 404-411
57. Naranjo CA, Tremblay LK, Busto UE. The role of the brain reward system in depression. Prog Neuropharmacol Biol Psychiatry. 2001 ; 25: 781-823
58. Nutt DJ, Baldwin DS, Clayton AH, et al. Consensus statement and research needs: The role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry. 2006 ; 67: S46-49
59. Nutt DJ, Demyttenaere K, Janka Z, et al. The other face of depression, reduced positive affect: The role of catecholamines in causation and cure. J Psychopharmacol. 2007 ; 21: 461-471
60. Oei TI, Verhoeven WM, Westenberg HG, et al. Anhedonia, suicide ideation and dexamethasone nonsuppression in depressed patients. J Psychiatr Res. 1990 ; 24: 25-35
61. Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol. 1954 ; 47: 419-427
62. Olino TM, McMakin DL, Dahl RE, et al. 'I won, but I'm not getting my hopes up': Depression moderates the relationship of outcomes and reward anticipation. Psychiatry Res. 2011 ; 194: 393-395
63. Papakostas GI, Shelton RC, Smith J, et al. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: A meta-Analysis. J Clin Psychiatry. 2007 ; 68: 836-831
64. Park J, Wheeler RA, Fontillas K, et al. Catecholamines in the bed nucleus of the stria terminalis reciprocally respond to reward and aversion. Biol Psychiatry. 2012 ; 71: 327-334
65. Pecina S, Berridge KC. Hedonic hot spot in nucleus accumbens shell: Where do mu-opioids cause increased hedonic impact of sweetness?. J Neurosci. 2005 ; 25: 11777-11786
66. Pelizza L, Ferrari A. Anhedonia in schizophrenia and major depression: State or trait?. Ann Gen Psychiatry. 2009 ; 8: 22
67. Phillips ML, Drevets WC, Rauch SL, et al. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry. 2003 ; 54: 504-514
68. Randrup A, Munkvad I, Fog R, et al Current Developments in Psychopharmacology. Essman WB Valzelli S, ed. New York: Spectrum Publications ; 1975: 206-248.
69. Reimherr FW, Martin ML, Eudicone JM, et al. A pooled MADRS/IDS cross-correlation analysis: Clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole. J Clin Psychopharmacol. 2010 ; 30: 300-305
70. Remy P, Doder M, Lees A, et al. Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system. Brain. 2005 ; 128: 1314-1322
71. Ribot T The Psychology of Emotions. London: W Scott Ltd ; 1897 :
72. Rush JA, Trivedi MH, Stewart JW, et al. Combining medications to enhance depression outcomes (CO-MED): Acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry. 2011 ; 168: 689-701
73. Ruther E, Degner D, Munzel U, et al. Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial. Pharmacopsychiatry. 1999 ; 32: 127-135
74. Salamone JD, Correa M, Farrar A, et al. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacol. 2007 ; 191: 461-482
75. Sarchiapone M, Carli V, Camardese G, et al. Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Res. 2006 ; 147: 243-248
76. Schatzberg AF, Rothschild AJ, Langlais PJ, et al. A corticosteroid/ dopamine hypothesis for psychotic depression and related states. J Psychiartry Res. 1985 ; 19: 57-64
77. Shankman SA, Nelson BD, Harrow M, et al. Does physical anhedonia play a role in depression? A 20-year longitudinal study. J Affect Disord. 2010 ; 120: 170-176
78. Sharot T, Shiner T, Brown AC, et al. Dopamine enhances expectation of pleasure in humans. Curr Biol. 2009 ; 19: 2077-2080
79. Shelton RC, Tomarken AJ. Can recovery from depression be achieved?. Psychiatry Serv. 2011 ; 52: 1469-1478
80. Smith KS, Tindell AJ, Aldridge JW, et al. Ventral pallidum roles in reward and motivation. Behav Brain Res. 2009 ; 196: 155-167
81. Smoski MJ, Rittenberg A, Dichter GS. Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards. Psychiatry Res. 2011 ; 194: 263-270
82. Snaith RP, Hamilton M, Morley S, et al. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995 ; 167: 99-103
83. Spijker J, Bijl RV, De Graaf R, et al. Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand. 2001 ; 103: 122-130
84. Stein DJ. Depression, anhedonia, and psychomotor symptoms: The role of dopaminergic neurocircuitry. CNS Spectr. 2008 ; 13: 561-565
85. Sugam JA, Day JJ, Wightman RM, et al. Phasic nucleus accumbens dopamine encodes risk-based decision-making behaviour. Biol Psychiatry. 2012 ; 71: 199-205
86. Thase ME, Haight BR, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: A meta-Analysis of original data from 7 randomized controlled trials. J Clin Psychiatr. 2005 ; 66: 974-981
87. Thase ME, Hersen M, Bellack AS, et al. Validation of a Hamilton subscale for endogenomorphic depression. J Affect Disord. 1983 ; 5: 267-278
88. Tomarken AJ, Dichter GS, Freid C, et al. Assessing the effects of bupropion SR on mood dimensions of depression. J Affect Disord. 2004 ; 78: 235-241
89. Treadway MT, Zald DH. Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neurosci Biobehav Rev. 2011 ; 35: 537-535
90. Uher R, Perlis RH, Heniqsbeg N, et al. Depression symptom dimensions as predictors of antidepressant treatment outcome: Replicable evidence for interest-Activity symptoms. Psychol Med. 2012 ; 42: 967-980
91. Ungless MA. Dopamine: The salient issue. Trends Neurosci. 2004 ; 27: 702-706
92. Volkow ND, Wang GJ, Fowler JS, et al. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci USA. 1996 ; 93: 10388-10392
93. Wacker J, Dillon DG, Pizzagalli DA. The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: Integration of resting EEG, fMRI, and volumetric techniques. Neuroimage. 2009 ; 46: 327-337
94. Walter M, Henning A, Grimm S, et al. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch Gen Psychiatry. 2009 ; 66: 478-486
95. Watson D, Clark LA, Carey G. Positive and negative affectivity and their relation to anxiety and depressive disorders. J Abnorm Psychol. 2008 ; 97: 346-353
96. Willner P, Hale AS, Argyropoulos S. Dopaminergic mechanism of antidepressant action in depressed patients. J Affect Disord. 2005 ; 86: 37-45
97. Woodward DJ, Chang JY, Janak P, et al. Mesolimbic neuronal activity across behavioral states. Ann NY Acad Sci. 1999 ; 87: 91-112
98. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO ; 1992 :
99. Yadid G, Friedman A. Dynamics of the dopaminergic system as a key component to the understanding of depression. Prog Brain Res. 2008 ; 172: 265-286